MedTrace Logo

Validation of a Shared Decision-Making Tool for Multiple Sclerosis

NCT04122989 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 501

Last updated 2022-05-09

No results posted yet for this study

Summary

This study evaluates a novel shared decision making tool for multiple sclerosis (MS). Half the patients will be given access to MS-SUPPORT before their scheduled appointment with their healthcare provider, the other half will not be given access.

Conditions

Interventions

OTHER

MS-SUPPORT

MS-SUPPORT is a shared decision making tool designed to be used by patients and providers.

Sponsors & Collaborators

  • EMD Serono

    collaborator INDUSTRY

  • Multiple Sclerosis Association of America

    collaborator UNKNOWN

  • Shared Decision Making Resources

    lead OTHER

Principal Investigators

  • Nananda Col, MD, MPH, MPP · Shared Decision Making Resources

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-12
Primary Completion
2020-10-26
Completion
2021-12-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04122989 on ClinicalTrials.gov